ONTY Key Stats
- Oncothyreon Announces Full Year and Fourth Quarter 2013 Financial Results Conference Call noodls 03/06 10:06 ET
- Oncothyreon (ONTY) Jumps: Stock Moves 9.9% Higher - Tale of the Tape Zacks 03/06 09:46 ET
- Oncothyreon (ONTY) Jumps: Stock Moves 9.9% Higher Yahoo 03/06 07:51 ET
- Oncothyreon to Present at Cowen and Company 34th Annual Health Care Conference noodls 02/26 08:51 ET
- Oncothyreon Inc. (ONTY) in Focus: Stock up 9.3% - Tale of the Tape Zacks 02/26 03:18 ET
- NewLink's Pancreatic Cancer Vaccine and the Feuerstein-Ratain Rule The Street 02/26 02:33 ET
- Oncothyreon Inc. (ONTY) in Focus: Stock up 9.3% Yahoo 02/26 02:28 ET
- 8:02 am Oncothyreon and Array BioPharma (<a href="http://feeds.finance.yahoo.com/q?s=arry" name="arry">ARRY</a>) announce initiation of phase 1b trial of ONT-380 in combination with TDM-1 in patients with metastatic HER2+ breast cancer Yahoo 02/20 15:57 ET
- Oncothyreon and Array BioPharma Announce Initiation of Phase 1b Trial of ONT-380 in Combination with TDM-1 in Patients with Metastatic HER2+ Breast Cancer noodls 02/20 10:14 ET
- Oncothyreon and Array BioPharma Announce Initiation of Phase 1b Trial of ONT-380 in Combination with Capecitabine and/or Trastuzumab in Patients with Metastatic HER2+ Breast Cancer noodls 02/03 09:17 ET
ONTY Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Oncothyreon is up 64.68% over the last year vs S&P 500 Total Return up 24.21%, Array BioPharma up 14.29%, and Actelion up 98.29%.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for ONTY
Pro Strategies Featuring ONTY
Did Oncothyreon make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Headquarters Country: United States
- Headquarters State/Province: Washington
- Incorporation Country: United States
- Incorporation State/Province: Delaware
Oncothyreon Inc., is a clinical-stage biopharmaceutical company. It develops and markets synthetic vaccines & small molecules that treat the lives & outcomes of cancer patients.